Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
- 1 May 2012
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 26 (10), 1055-1069
- https://doi.org/10.1101/gad.187252.112
Abstract
Human melanocytic nevi (moles) are benign lesions harboring activated oncogenes, including BRAF. Although this oncogene initially acts mitogenically, eventually, oncogene-induced senescence (OIS) ensues. Nevi can infrequently progress to melanomas, but the mechanistic relationship with OIS is unclear. We show here that PTEN depletion abrogates BRAFV600E-induced senescence in human fibroblasts and melanocytes. Correspondingly, in established murine BRAFV600E-driven nevi, acute shRNA-mediated depletion of PTEN prompted tumor progression. Furthermore, genetic analysis of laser-guided microdissected human contiguous nevus–melanoma specimens recurrently revealed identical mutations in BRAF or NRAS in adjacent benign and malignant melanocytes. The PI3K pathway was often activated through either decreased PTEN or increased AKT3 expression in melanomas relative to their adjacent nevi. Pharmacologic PI3K inhibition in melanoma cells suppressed proliferation and induced the senescence-associated tumor suppressor p15INK4B. This treatment also eliminated subpopulations resistant to targeted BRAFV600E inhibition. Our findings suggest that a significant proportion of melanomas arise from nevi. Furthermore, these results demonstrate that PI3K pathway activation serves as a rate-limiting event in this setting, acting at least in part by abrogating OIS. The reactivation of senescence features and elimination of cells refractory to BRAFV600E inhibition by PI3K inhibition warrants further investigation into the therapeutic potential of simultaneously targeting these pathways in melanoma.Keywords
This publication has 66 references indexed in Scilit:
- A novel recurrent mutation in MITF predisposes to familial and sporadic melanomaNature, 2011
- In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of MelanomaCell, 2011
- Exome sequencing identifies GRIN2A as frequently mutated in melanomaNature Genetics, 2011
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote TumorigenesisMolecular Cell, 2011
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetNature, 2011
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4Nature Genetics, 2009
- Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanomaNature Genetics, 2009
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- A negative feedback signaling network underlies oncogene-induced senescenceCancer Cell, 2006
- Mutations of the BRAF gene in human cancerNature, 2002